FDA Inspection 1335766 — Eurofins Amatsi Analytics
The FDA completed an inspection of Eurofins Amatsi Analytics on May 20, 2026 in Fontenilles. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 20, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Fontenilles (France)
Additional Details
Mutual Recognition Agreement (MRA)